MKI67 and ductal breast carcinoma in situ: On surgical specimen, lower rate of HR positive (65.9% vs. 78.7%, p = 0.003) and higher rate of high Ki-67 (37.8% vs. 19.9%, p < 0.001) were observed in patients with DCIS upgraded to invasive cancer.